NRSA Training

修订后的CTSA机构培训核心(TL1)旨在利用新的 泽西临床和翻译科学联盟(NJ ACTS)，这个伞形组织将提供 支持和加强新泽西州临床和转化性研究和培训的基础设施。领头羊 罗格斯生物医学和健康科学(RBHS)，由罗格斯翻译研究所管理 医学和科学(RITMS)，新泽西州ACTS由三所大学(罗格斯大学， 普林斯顿大学和新泽西理工学院)和社区组织， 医院、社区卫生中心、门诊诊所、数据中心和两个健康信息交换中心。 这种独特而充满活力的环境将使我们能够创建一个强大而有效的平台来培训下一代 一代翻译研究人员。创新的翻译研究既不能教授，也不能完成 在竖井里。我们希望鼓励我们的实习生从他们博士经历的最早阶段开始考虑， 他们的研究成果对疾病的诊断、治疗和预防的影响和应用。 为了实现这一点，而不是将我们的培训限制在特定的部门或计划中，我们聚集了 首批在基础生物医学和生物工程方面具有成熟专业知识的高生产率导师 研究、临床研究、生物信息学、生物统计学、机器学习、流行病学、卫生政策等 将联合起来为我们的实习生提供指导的关键领域。我们的跨学科团队已经团结起来 作为“新泽西州ACTS导师学院”，它将成为TL1培训的教育平台。至 加强这一经验的翻译性质，导师学院将由我们两个新泽西州分享 ACTS学员(TL1)和学者(KL2)。战略上，我们将重点关注由学生组成的实习生人才库 通过选择学位(S)和/或研究生课程，表达了对翻译基础科学的兴趣 将发现和概念转化为与疾病相关的应用(医学博士/博士药学/博士、DPT/博士、生物技术、 生物医学工程和精神病学博士)。在项目领导和他们的指导团队的帮助下， 每位学员将设计一套核心和选修课程、工作坊、研讨会和沉浸课程。 经验，以实现“精准”培训量身定做的需求和研究事业的愿望。此外，我们 将在以下背景下使用有效和可靠的指标系统地评估我们的计划成果 内部和外部评估团队。

This revised CTSA Institutional Training Core (TL1) has been designed to leverage the strengths of The New Jersey Alliance for Clinical and Translational Science (NJ ACTS), the umbrella organization that will provide an infrastructure to support and enhance clinical and translational research and training in New Jersey. Led by Rutgers Biomedical and Health Sciences (RBHS) and administered by the Rutgers Institute for Translational Medicine and Science (RITMS), NJ ACTS comprises an Alliance of three universities (Rutgers University, Princeton University, and the New Jersey Institute of Technology) and community-based organizations, hospitals, community health centers, outpatient practices, data centers and two Health Information Exchanges. This unique and dynamic environment will allow us to create a robust and effective platform to train the next generation of translational researchers. Innovative translational research can neither be taught nor accomplished in a silo. We want to encourage our trainees to consider, from the earliest stages of their doctoral experience, the implication and application of their research efforts to the diagnosis, treatment and prevention of disease. To accomplish this, rather than limit our training within a particular department or program, we have gathered an initial cohort of highly productive mentors with proven expertise in basic biomedical and bioengineering research, clinical research, bioinformatics, biostatistics, machine learning, epidemiology, health policy and other key areas that will coalesce to provide mentorship to our trainees. Our cross-disciplinary team has been united as the “NJ ACTS Academy of Mentors” which will be the educational platform for this TL1 training effort. To enhance the translational nature of this experience, the Academy of Mentors will be shared by both our NJ ACTS Trainees (TL1) and Scholars (KL2). Strategically, we will focus on a trainee pool composed of students who have expressed, by choice of degree(s) and/or graduate program, an interest in translating basic science findings and concepts into disease-relevant applications (MD/PhD. PharmD/PhD, DPT/PhD, Biotechnology, Biomedical Engineering and Psychiatry PhD). With the help of the program leadership and their mentoring team, each trainee will design a curriculum of core and elective courses, workshops, seminars and immersion experiences, to achieve “precision” training tailored to their needs and research career aspirations. Further, we will systematically assess our programmatic outcomes using valid and reliable metrics within the context of an internal and external evaluation team.